DOCSLIB.ORG

Measurement of Dextromethorphan and Dextrorphan in Human Urine Using a Novel Isocratic Liquid Chromatography – Tandem Mass Spectrometry Method

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Measurement of Dextromethorphan and Dextrorphan in Human Urine Using a Novel Isocratic Liquid Chromatography – Tandem Mass Spectrometry Method Measurement of Dextromethorphan and Dextrorphan in Human Urine using a Novel Isocratic Liquid Chromatography – Tandem Mass Spectrometry Method. Denise A McKeown, Terry D Lee, David W Holt and Atholl Johnston. Analytical Unit, St George’s Hospital Medical School, London, UK. CALIBRATION CURVES REPRESENTATIVE CHROMATOGRAMS CH INTRODUCTION CH3 3 Figure 4 represents a typical chromatogram for a urine N N Figure 2 and Figure 3 show the calibration curves for both dextromethorphan and dextrorphan urine calibrators calibrator. The retention times of dextromethorphan, The analysis of dextromethorphan and its metabolites; respectively. The assay range for dextromethorphan and dextrorphan and ethylmorphine are approximately 4.4, 4.3 dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan was 0 to 5060ng/mL and 0 to 4950ng/mL for dextrorphan. and 4.7 minutes respectively. (Figure 1), has been encountered in both clinical and forensic settings. However this poster will focus on dextromethorphan H C O HO D e x t r o m e t h o r p h a n ( 4 .4 m in s ) and dextrorphan. 3 Dextromethorphan Dextromethorphan has therapeutic properties as an antitussive Dextromethorphan Dextrorphan 3 0 0 0 0 2 5 0 0 0 7 ) drug and is available without prescription as a component of s H p 2 0 0 0 0 c H ( oo 6 ii y tt t cough remedies. The drug can be orally administered and is i 1 5 0 0 0 s N aa N 5 n e RR t widely available, allowing it to be exploited in research as a 1 0 0 0 0 n I aa 4 1-2 ee probe drug for oxidative phenotyping. A large number of rr 5 0 0 0 AA 3 kk 0 drugs are metabolised in the body by the Cytochrome P450 aa 2 0 1 2 3 4 5 6 ee (CYP) enzymes, which are highly polymorphic. CYP3A4, PP 1 C o n c e n t ra t i o n (n g / m L ) CYP2C19 and CYP2D6 are a few examples of these enzymes HO 0 3 H3C O D e x t r o r p h a n (4 .3 m in s ) involved in the biotransformations. Dextromethorphan is 0 1000 2000 3000 4000 5000 3-methoxymorphinan 3-hydroxymorphinan metabolised to the 0-demethylated metabolite, dextrorphan, via Concentration (ng/mL) 1 4 0 0 0 o 1 2 0 0 0 i CYP2D6 enzyme pathway. The ratio of dextromethorphan to t Figure 1: Structures of Dextromethorphan and its metabolites a 1 0 0 0 0 R dextrorphan reflects the CYP2D6 enzyme activity and can be a e 8 0 0 0 Figure 2: Dextromethorphan calibration curve. Regression linear r A used to classify an individual as either a poor or extensive k 6 0 0 0 through zero, weighting (1/(x*x)), y = 0.00125x, r = 0.9989. a e 4 0 0 0 1 EXPERIMENTAL P metaboliser. 2 0 0 0 Dextromethorphan and dextrorphan can be routinely detected D extrorphan 0 0 1 2 3 4 5 6 and quantitated by gas chromatography-mass spectrometry Extraction C o n c e n t ra t i o n (n g / m L ) (GC/MS) in our forensic toxicology service, and has been Internal standard (ethylmorphine, 2.5mg/L, 100µL), sodium 4.0 3.5 E th y l M o r p h in e (4 .7 m in s ) present in several post mortem cases. This type of abuse is not hydroxide (100µL, 1M) and methyl tertiary butyl ether (2mL) oo ii 3.0 tt unexpected as a desperate individual will try to use any legal or aa 7 0 0 0 were added to each urine calibrator, control or human RR 2.5 aa 6 0 0 0 ee illegal drug that is readily available to them. The recreational ) sample (100µL). The tubes were capped, mixed (approx 5 rr 2.0 s 5 0 0 0 AA p c ( kk abuse of dextromethorphan (DXM) is also increasing. Its use is minutes) and then centrifuged (3500rpm, 5 minutes). The 1.5 4 0 0 0 y aa t i ee s 1.0 n 3 0 0 0 PP characterised in two ways; firstly as a drug knowingly being upper organic layer from each was transferred to a tube e t n consumed and secondly being sold as ecstasy. Countries containing 0.1% formic acid (500µL). After mixing (approx. 5 0.5 I 2 0 0 0 1 0 0 0 4 0.0 reporting use in these contexts include America, Korea and minutes) and centrifugation (3500rpm, 5minutes) the top 0 0 1000 2000 3000 4000 5000 Spain5. Its increased use is believed to be related to cost, legal solvent layer was removed and discarded. The aqueous 0 1 2 3 4 5 6 Concentration (ng/m L) T i m e (m in s ) access and wide availability. extracts were then transferred to autosampler vials ready for analysis. The human urine samples were pre-incubated with Figure 4: Representative chromatogram of a urine calibrator; β-glucuronidase for a minimum of 12 hours prior to Figure 3: Dextrorphan calibration curve. Regression linear AIM dextromethorphan (4.4min), dextrorphan (4.3min) and ethylmorphine extraction. through zero, weighting (1/x*x)), y = 0.000701x, r = 0.9984. (4.7min). To develop a liquid chromatography-tandem mass HPLC Conditions and MS Parameters spectrometry method (LC/MS/MS) for the measurement of SUMMARY The HPLC equipment consisted of a Perkin Elmer PE200 dextromethorphan and dextrorphan in human urine. This series autosampler (injection volume, 10µL) and pump. A method was to be used in a clinical study investigating oxidative The aim to develop a method for the measurement of dextromethorphan and dextrorphan in human urine using LC/MS/MS was silica column (Supelcosil LC-Si, 10cm x 4.6mm, 5µm) was phenotyping. Many researchers have measured achieved. A novel isocratic method using a silica column gave good retention of the drug, metabolite and internal standard. An maintained at 50°C in a Schimadzu CTO-10A column oven. dextromethorphan and dextrorphan using high performance isocratic method has advantages over using a gradient method because it does not use as much mobile phase and avoids long The mobile phase, consisting of acetonitrile/de-ionised liquid chromatography (HPLC) with fluorescence, UV or mass equilibration times allowing a much more efficient method for detection. This method will be used in our clinical toxicology water/formic acid (50/50/0.2) was pumped at 1mL/min and spectrometric detection. Published methods commonly use C8 laboratory for clinical studies investigating oxidative phenotyping. The method can also be used for any assays that require the split 10:1 before entering the mass spectrometer. columns either isocratically or with a gradient system in an measurement of these drugs and can be used for different sample matrices such as blood. In the forensic toxicology laboratory A Sciex API2000 triple quadrupole mass spectrometer attempt to reduce the difference in elution times between these we currently use GC/MS for the qualitative and quantitative analysis of dextromethorphan and dextrorphan. However, the equipped with a turbo-ion spray interface maintained at two compounds. Gradient systems are preferred, but this often LC/MS/MS method has the advantage that it uses less sample volume for detection. This will be advantageous when there is 500°C was used for detection. The method was run in results in longer equilibration times and more solvent waste. limited sample which is often the case with post-mortem samples. positive ionisation mode and set to detect the precursor and Here we report a LC/MS/MS method using a novel isocratic product ions of dextromethorphan (m/z: 272.04/212.98), system which elutes dextromethorphan, dextrorphan and the dextrorphan (m/z: 257.99/198.80 and ethylmorphine (m/z: internal standard, ethylmorphine in less than 6 minutes. REFERENCES 314.01/165.08). Total run time of method was 6.0mins. 1. S.S. Vengurlekar et al., J. Pharm. Biomed. Anal. 30 (2002) 113-124 4. H. Chung et al., Ann. N.Y. Acad. Sci. 1025 (2004) 458-464 2. J.M. Hoskins et al., J. Chromatogr. B 696 (1997) 81-87 5. S. Abanades, A.M. Peiro, M. Farre, Med Clin (Barc) 123(8) (2004) 3. S.A. Testino Jr, G. Patonay, J. Pharm. Biomed. Anal. 30 (2003) 305-311 1459-1467.
Load more

Recommended publications
  • Nitric Oxide and the Neurotoxic Effects of Methamphetamine and 3,4-Methylenedioxymethamphetamine1
    0022-3565/97/2802-0941$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 280, No. 2 Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics Printed in U.S.A. JPET 280:941–947, 1997 Nitric Oxide and the Neurotoxic Effects of Methamphetamine and 3,4-Methylenedioxymethamphetamine1 TERRI TARASKA and KEVIN T. FINNEGAN Departments of Psychiatry (T.T., K.T.F.), Pharmacology and Toxicology (K.T.F.) and Neuroscience (K.T.F.), University of Utah School of Medicine and the Veterans Administration Medical Center, Salt Lake City, Utah Accepted for publication October 21, 1996 ABSTRACT The role of nitric oxide (NO) in the long-term, amine-depleting antagonized the hyperthermic effects of METH, reducing co- effects of methamphetamine (METH) and 3,4-methyl- lonic temperatures in mice by a mean of 3°C, in comparison enedioxymethamphetamine (MDMA) was investigated in the with control. Moreover, if the hypothermic effects of L-NAME in rodent central nervous system. The NO synthase inhibitor NG- METH-treated mice were prevented by raising the ambient nitro-L-arginine methyl ester (L-NAME) antagonized the dopa- room temperature, the dopamine-depleting actions of the stim- mine- and serotonin-depleting effects of both METH and ulant were fully restored. The latter findings suggest that it is the MDMA. The protective actions of L-NAME in METH-treated hypothermic actions of L-NAME, rather than its NO inhibitory mice were reversed by prior administration of the NO generator properties, that are responsible for the prevention of neurotox- G G isosorbide dinitrate. However, pretreatment with N -mono- icity.
    [Show full text]
  • Hallucinogens
    Hallucinogens What Are Hallucinogens? Hallucinogens are a diverse group of drugs that alter a person’s awareness of their surroundings as well as their thoughts and feelings. They are commonly split into two categories: classic hallucinogens (such as LSD) and dissociative drugs (such as PCP). Both types of hallucinogens can cause hallucinations, or sensations and images that seem real though they are not. Additionally, dissociative drugs can cause users to feel out of control or disconnected from their body and environment. Some hallucinogens are extracted from plants or mushrooms, and others are synthetic (human-made). Historically, people have used hallucinogens for religious or healing rituals. More recently, people report using these drugs for social or recreational purposes. Hallucinogens are a Types of Hallucinogens diverse group of drugs Classic Hallucinogens that alter perception, LSD (D-lysergic acid diethylamide) is one of the most powerful mind- thoughts, and feelings. altering chemicals. It is a clear or white odorless material made from lysergic acid, which is found in a fungus that grows on rye and other Hallucinogens are split grains. into two categories: Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) comes from certain classic hallucinogens and types of mushrooms found in tropical and subtropical regions of South dissociative drugs. America, Mexico, and the United States. Peyote (mescaline) is a small, spineless cactus with mescaline as its main People use hallucinogens ingredient. Peyote can also be synthetic. in a wide variety of ways DMT (N,N-dimethyltryptamine) is a powerful chemical found naturally in some Amazonian plants. People can also make DMT in a lab.
    [Show full text]
  • DXM Fast Facts
    What is DXM? doses—usually at least half an 8-ounce ketamine. While under the influence of bottle—by drinking the liquid very the drug, which can last for as long as DXM (dextromethorphan) is a quickly. (Consumption of large quanti- 6 hours, DXM abusers risk injuring cough suppressant available in a ties of cough syrup induces vomiting. themselves and others because of the variety of over-the-counter cough and Thus, to achieve the desired effects, drug’s effects on visual perception and cold medications. DXM is abused abusers must drink the product quickly cognitive processes. because, when taken in doses that enough to allow the body to absorb the In addition, individuals who ingest dramatically exceed those recom- DXM before vomiting occurs.) mended by physicians and pharma- high doses of DXM risk hyperthermia cists, it produces hallucinations and The availability of powdered extrac- (exceptionally high fever), particularly if a sense of dissociation. tions of DXM has resulted in abusers they use the drug in a hot environment either inhaling the powder (snorting) or or while physically exerting themselves— What does DXM look like? repackaging it in capsules, which are such as at a rave or dance club. Other then swallowed. risks associated with DXM abuse As an over-the-counter medication, include nausea, abdominal pain, vomit- DXM is available in various forms Who abuses DXM? ing, irregular heartbeat, high blood including liquids, lozenges, tablets, pressure, headache, numbness of capsules, and gel caps. In addition, DXM It is difficult to gauge the extent of fingers and toes, loss of consciousness, powder—prepared by extracting the drug DXM abuse in the United States seizures, brain damage, and death.
    [Show full text]
  • Introduced B.,Byhansen, 16
    LB301 LB301 2021 2021 LEGISLATURE OF NEBRASKA ONE HUNDRED SEVENTH LEGISLATURE FIRST SESSION LEGISLATIVE BILL 301 Introduced by Hansen, B., 16. Read first time January 12, 2021 Committee: Judiciary 1 A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to 2 amend sections 28-401, 28-405, and 28-416, Revised Statutes 3 Cumulative Supplement, 2020; to redefine terms; to change drug 4 schedules and adopt federal drug provisions; to change a penalty 5 provision; and to repeal the original sections. 6 Be it enacted by the people of the State of Nebraska, -1- LB301 LB301 2021 2021 1 Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2 2020, is amended to read: 3 28-401 As used in the Uniform Controlled Substances Act, unless the 4 context otherwise requires: 5 (1) Administer means to directly apply a controlled substance by 6 injection, inhalation, ingestion, or any other means to the body of a 7 patient or research subject; 8 (2) Agent means an authorized person who acts on behalf of or at the 9 direction of another person but does not include a common or contract 10 carrier, public warehouse keeper, or employee of a carrier or warehouse 11 keeper; 12 (3) Administration means the Drug Enforcement Administration of the 13 United States Department of Justice; 14 (4) Controlled substance means a drug, biological, substance, or 15 immediate precursor in Schedules I through V of section 28-405. 16 Controlled substance does not include distilled spirits, wine, malt 17 beverages, tobacco, hemp, or any nonnarcotic substance if such substance 18 may, under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
    [Show full text]
  • Bath Salts”: Synthetic Psychostimulants and Hallucinogens Silas W
    “E” to “Bath Salts”: Synthetic Psychostimulants and Hallucinogens Silas W. Smith, MD, FACEP CSAM. Addiction Medicine Review Course 2014. September 6, 2014 REFERENCES Presentation Bialer PA. Designer drugs in the general hospital. Psychiat Clin N Am. 2002;25:231-43. Babu KM, McCurdy CR, Boyer EW. Opioid receptors and legal highs: Salvia divinorum and Kratom. Clin Toxicol (Phila). 2008;46:146-52. Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008;103:1048-50. Braden MR, Parrish JC, Naylor JC, Nichols DE. Molecular interaction of serotonin 5- HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Mol Pharmacol. 2006;70:1956-64. Brents LK, Reichard EE, Zimmerman SM, Moran JH, Fantegrossi WE, Prather PL. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One. 2011;6:e21917. Center for Substance Abuse Treatment, SAMHSA. Inhalants. Substance Abuse Treatment Advisory. March 2003;3(1):1-8. Chambers JJ, Kurrasch-Orbaugh DM, Parker MA, Nichols DE. Enantiospecific Synthesis and Pharmacological Evaluation of a Series of Super-Potent, Conformationally Restricted 5-HT2A/2C Receptor Agonists. J Med Chem. 2001;44:1003-10. Cohen BMZ, Butler R. BZP-party pills: A review of research on benzylpiperazine as a recreational drug. Int J Drug Policy. 2011;22:95-101. Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J Pharmacol Exp Ther.
    [Show full text]
  • Nitrous Oxide Revisited
    Anesthesiology 2005; 103:845–54 © 2005 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Nitrous Oxide Revisited Evidence for Potent Antihyperalgesic Properties Philippe Richebe´ , M.D., Ph.D.,* Cyril Rivat, Ph.D.,† Cyril Creton, M.Sc.,† Jean-Paul Laulin, Ph.D.,‡ Pierre Maurette, M.D., Ph.D.,§ Marc Lemaire, M.D.,࿣ Guy Simonnet, Ph.D.# Background: Although opioids are unsurpassed analgesics NITROUS oxide is commonly used in humans for pain for surgery, they also induce an N-methyl-D-aspartate–depen- relief. Experimental animal studies have revealed that dent enhancement of postoperative hyperalgesia. Because ni- nitrous oxide induces opioid peptide release in the peri- trous oxide (N2O) has anti–N-methyl-D-aspartate properties, the purpose of this study was to evaluate nitrous oxide ability to aqueductal brainstem, leading to disinhibition (activa- prevent such an opioid-induced hyperalgesia in rats. tion) of the descending noradrenergic inhibitory path- Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/103/4/845/360312/0000542-200510000-00024.pdf by guest on 01 October 2021 ␥ Methods: First, preventive effects of 50/50% N2O–O2 on the ways via inhibition of -aminobutyric acid–mediated development of delayed hyperalgesia observed after inflamma- interneurons. This results in a negative modulation of the 1–3 tory pain (hind paw carrageenan injection on D0) were exam- nociceptive processes at the spinal cord level. ined for several days. Second, the ability of nitrous oxide (10– A challenging hypothesis is that the nitrous oxide an- 40%) to limit opioid-induced hyperalgesia induced by fentanyl algesic effect is not limited to its antinociceptive effect was evaluated in nonsuffering rats.
    [Show full text]
  • Signs & Symptoms of Dextromethorphan Exposure From
    Signs & Symptoms of Dextromethorphan Exposure from YouTube Michael Chary1, Emily H. Park2, Andrew McKenzie1, Julia Sun1, Alex F. Manini3, Nicholas Genes4* 1 Ichan School of Medicine at Mount Sinai, New York, New York, United States of America, 2 Rutgers New Jersey Medical School, Newark, New Jersey, United States of America, 3 Division of Medical Toxicology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America, 4 Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America Abstract Detailed data on the recreational use of drugs are difficult to obtain through traditional means, especially for substances like Dextromethorphan (DXM) which are available over-the-counter for medicinal purposes. In this study, we show that information provided by commenters on YouTube is useful for uncovering the toxicologic effects of DXM. Using methods of computational linguistics, we were able to recreate many of the clinically described signs and symptoms of DXM ingestion at various doses, using information extracted from YouTube comments. Our study shows how social networks can enhance our understanding of recreational drug effects. Citation: Chary M, Park EH, McKenzie A, Sun J, Manini AF, et al. (2014) Signs & Symptoms of Dextromethorphan Exposure from YouTube. PLoS ONE 9(2): e82452. doi:10.1371/journal.pone.0082452 Editor: Renaud Lambiotte, University of Namur, Belgium Received May 28, 2013; Accepted October 23, 2013; Published February 12, 2014 Copyright: ß 2014 Chary et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
    [Show full text]
  • Hallucinogens and Dissociative Drugs
    Long-Term Effects of Hallucinogens See page 5. from the director: Research Report Series Hallucinogens and dissociative drugs— which have street names like acid, angel dust, and vitamin K—distort the way a user perceives time, motion, colors, sounds, and self. These drugs can disrupt a person’s ability to think and communicate rationally, or even to recognize reality, sometimes resulting in bizarre or dangerous behavior. Hallucinogens such as LSD and psilocybin cause emotions to swing wildly and HALLUCINOGENS AND real-world sensations to appear unreal, sometimes frightening. Dissociative drugs like PCP, ketamine, DXM, and Salvia DISSOCIATIVE DRUGS divinorum may make a user feel out of control and disconnected from their body Including LSD, PCP, Ketamine, Psilocybin, and environment. Salvia, Peyote, and Dextromethorphan In addition to their short-term effects on perception and mood, hallucinogenic What Are drugs are associated with psychotic- Hallucinogens and like episodes that can occur long after a person has taken the drug, and Dissociative Drugs? dissociative drugs can cause respiratory depression, heart rate abnormalities, and allucinogens are a class of drugs that cause hallucinations—profound a withdrawal syndrome. The good news is distortions in a person’s perceptions of reality. Hallucinogens can be found in that use of hallucinogenic and dissociative Hsome plants and mushrooms (or their extracts) or can be man-made, and they drugs among U.S. high school students, are commonly divided into two broad categories: classic hallucinogens (such as LSD) in general, has remained relatively low in and dissociative drugs (such as PCP). When under the influence of either type of drug, recent years.
    [Show full text]
  • The Joint French-US Seminar on Phencyclidine and Related
    TIPS deptember 1983 363 p-Amin&mmcacid 1 Dihydmplertdtns 1 Dihydmiok acid ’ J Lsym- I I 1 Dit-rfdrotolkacid ) I The joint French-US seminar on Tetrahydroblic acid phencyclidine and related arylcyclohexylamines Protein syllth8sis A joint French-US seminar was held at La (tram OH/N) one of the most potent opioid Grande Motte (Montpellier) France, 20-24 analgesics known. Removal of the oxygen September 1982, to assess the current sci- group in this series produces compounds entific status of phencyclidine (PCP) and with PCP-like activity to varying degrees. related arylcyclohexylamines. The seminar Zimmerman and associates (Lilly) reported L______--:-______I was attended by 58 scientists interested in the discovery and characterization of a new Fig. 5. Flow diagram of purim,thymidine and pro- the chemistry, biochemistry, pharmacol- series of benzo(f)isoquinoline derivatives rein synthesis. ogy, therapeutic applications and drug that have stimulus discriminative properties abuse aspects of arylcyclohexylamines. similar to PCP. One of the most potent is problems presented and the management of Thirty-four American, 19 French, 3 Japan the methylcyclopropyl bridged iso research show important differences, it is ese, 1 British and 1 Israeli investigator quinoline, LY 154045. PCP-like effects essential that industry continues to recruit attended, representing each of the above were maximized with a hydroxyl sub its proper proportion of the available talent. major disciplines. The organizing commit- stituent in the aromatic ring. Medawar has commented that the ordi- tee consisted of E. F. Domino of the Uni- One of the major questions in PCP nary processes of scientific discovery are versity of Michigan and P.
    [Show full text]
  • 1 Dextromethorphan and Dextrorphan Influence Insulin Secretion By
    JPET Fast Forward. Published on July 14, 2020 as DOI: 10.1124/jpet.120.265835 This article has not been copyedited and formatted. The final version may differ from this version. JPET # 265835 Dextromethorphan and dextrorphan influence insulin secretion by interacting with 2+ KATP and L-type Ca channels in pancreatic β-cells Anne Gresch, Martina Düfer University of Münster, Pharmaceutical and Medicinal Chemistry, Dept. of Pharmacology, Corrensstraße 48, 48149 Münster, Germany Downloaded from jpet.aspetjournals.org at ASPET Journals on September 30, 2021 1 JPET Fast Forward. Published on July 14, 2020 as DOI: 10.1124/jpet.120.265835 This article has not been copyedited and formatted. The final version may differ from this version. JPET # 265835 Running Title: NMDA receptor antagonists and β-cells Section assignment for table of contents: Endocrine and Diabetes Address correspondence to: Prof. Dr. Martina Düfer Pharmaceutical and Medicinal Chemistry, Dept. of Pharmacology PharmaCampus Corrensstraße 48, 48149 Münster, Germany Downloaded from Phone: +49 251 83 33339; Fax: +49 251 83 32144 [email protected] jpet.aspetjournals.org Text pages: 18 Tables: 0 at ASPET Journals on September 30, 2021 Figures: 6 References: 42 Word count: Abstract: 250 Introduction: 614 Discussion: 1712 Key words: β-cell, cytosolic calcium, dextromethorphan, insulin secretion, NMDA receptor, KATP channel Abbreviations: a.u.: arbitrary fluorescence units, DXM: dextromethorphan, DXO: dextrorphan, FOPP: fraction of plateau phase, MEA: microelectrode array, NMDA: N-methyl- D-aspartate, SUR1-KO: sulfonylurea receptor 1 knockout 2 JPET Fast Forward. Published on July 14, 2020 as DOI: 10.1124/jpet.120.265835 This article has not been copyedited and formatted.
    [Show full text]
  • Drugfacts Cough and Cold Medicines Final
    Cough and Cold Medicine Abuse Some over-the-counter (OTC) and prescrip- tion cough and cold medicines contain active ingredients that are psychoactive (mind- altering) at higher-than-recommended dos- ages and are frequently abused for this pur- pose. These products may also contain oth- er drugs, such as expectorants and antihis- tamines, which are dangerous at high doses and compound the dangers of abuse. Two commonly abused cough and cold med- icines are: How Are Cough and Cold Medicines • Dextromethorphan (DXM), a cough Abused? suppressant and expectorant found in many OTC cold medicines. It may Cough and cold medicines are usually con- produce euphoria and dissociative ef- sumed orally in tablet, capsule, or syrup fects or even hallucinations when form. They may be mixed with soda for taken in quantities greater than the flavor and are often abused in combination recommended therapeutic dose. with other drugs, such as alcohol or mari- • Promethazine-codeine cough syrup, a juana. medication that contains codeine, an opioid that acts as a cough suppres- Because they are easily purchased in drug- sant and can also produce relaxation stores without a prescription, cough syr- and euphoria when consumed at a ups, pills, and gel capsules containing higher-than-prescribed dose. It also DXM—particularly “extra strength” contains promethazine HCl, an anti- forms—are frequently abused by young histamine that additionally acts as a people (who refer to the practice as “robo- sedative. Although only available by tripping” or “skittling”). To avoid nausea prescription, promethazine-codeine produced by high doses of the expectorant cough syrup is sometimes diverted guaifenesin commonly found in DXM- for abuse.
    [Show full text]
  • Clinical Guidelines for Ibogaine-Assisted Detoxification
    Clinical Guidelines for Ibogaine-Assisted Detoxification 1st Edition, Version 1.1 Originally Published: September 2015 Current Version: 1.1 (February 25, 2016) Authors: Jonathan Dickinson Jamie McAlpin, R.N. Clare Wilkins Christine Fitzsimmons, R.N. Paige Guion, R.N. Tanea Paterson Douglas Greene Bruno Rasmussen Chaves, M.D. Editorial Committee: Jeffrey Kamlet, M.D., DABAM, FASAM Roman Paskulin, M.D., Ph.D. Copyright © The Global Ibogaine Therapy Alliance, 2015-17 Some rights reserved. This text contained herein is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Legal Disclaimer This document is for informational purposes only. It offers no diagnoses or prescription. The information should not replace the counsel of a medical professional. It has been prepared for the purpose of assisting individuals compiling questions for their medical providers and potential considerations for medical providers consulting with their legal counsel to establish individual standards of practices. It is not intended, and is not suited to be used as, legally or medically sufficient and necessary standards. The authors and editors of this document served as free consultants and are not to be held individually liable for this document’s uses. Acknowledgements We would like to acknowledge those who made significant contributions to the content or structure of the document during our consultation phase. Particularly, Uwe Mass, M.D., Cornelius Van Dorp, M.D., Andrew Dekkinga, R.N., Jasen Chamoun, Suster Strubelt, Anah Van Dorp, Rocky Caravelli, Asha Caravelli, and Damian Thomas. And to all of others who have provided guidance and input throughout the development of these guidelines. This would not be possible without the pioneering work that was begun by Howard and Norma Lotsof, as well as the dozens of others who made significant contributions to the earliest stages of ibogaine research.
    [Show full text]